Daridorexant is named as a drug or biological intervention in 4 clinical trials in our USA, China and UK trial registers, 1 of which is recruiting. Lead sponsors include Idorsia Pharmaceuticals Ltd. (2), Wang Fengmei (1) and Xuanwu Hospital, Beijing (1). Registered phases: Observational and Phase 4. Conditions studied include Insomnia; Insomnia Disorder; Liver Cirrhosis.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06498128 | Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQยฎ (ClinicalTrials.gov ↗) Insomnia |
Observational | Recruiting |
| NCT07733414 | Evaluating the Efficacy and Safety of Daridorexant Transition From BZRAs in Insomnia Patients๏ผEASY-TIP๏ผ (ClinicalTrials.gov ↗) Insomnia Disorders |
Phase 4 | Not yet open |
| NCT07830303 | Daridorexant for Sleep Disturbance in Adults With Liver Cirrhosis (ClinicalTrials.gov ↗) Liver Cirrhosis, Sleep Disturbance, Hepatic Encephalopathy |
Phase 4 | Not yet open |
| NCT06393504 | Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant) Insomnia Disorder |
Observational | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Insomnia | 1 |
| Insomnia Disorder | 1 |
| Liver Cirrhosis | 1 |
| Sleep Disturbance | 1 |
| Hepatic Encephalopathy | 1 |
| Insomnia Disorders | 1 |
| Lead sponsor | Trials |
|---|---|
| Idorsia Pharmaceuticals Ltd. | 2 |
| Wang Fengmei | 1 |
| Xuanwu Hospital, Beijing | 1 |
| Register | Daridorexant trials |
|---|---|
| Clinical trials in USA | 2 |
| Clinical trials in China | 2 |
| Clinical trials in UK | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records โ it is not written from memory, and nothing here describes how Daridorexant works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Daridorexant (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.